• Issue
    Volume 116, Issue 8
    1841-2064
    15 April 2010

Commentary

Free Access

Commentary on effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466)

  • Pages: 1844-1846
  • First Published: 06 April 2010

In this commentary, the author notes that a recent report revealed deficiencies in European Organization for Research and Treatment of Cancer trial 26981 that remained unaddressed in an update of the study.

Review Articles

Free Access

The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor

  • Pages: 1847-1858
  • First Published: 06 April 2010

This review summarizes relevant data supporting the efficacy of imatinib in patients with locally advanced or metastatic gastrointestinal stromal tumor (GIST), with a focus on the role of high-dose imatinib (800 mg daily) therapy in the contemporary management paradigm of GIST.

Free Access

Disrupting established tumor blood vessels: An emerging therapeutic strategy for cancer

  • Pages: 1859-1871
  • First Published: 06 April 2010

Selectively targeting tumor vasculature with tumor-vascular disrupting agents (tumor-VDAs) represents a promising and innovative approach to improving the efficacy of standard anticancer therapies. Phase 2 clinical trials with the flavonoid tumor-VDA ASA404 have demonstrated activity, including an apparent survival advantage, from combination therapy in patients with nonsmall cell lung cancer. Phase 3 trials are ongoing.

Original Articles

Disease Site

Breast Disease

Free Access

Angiosarcoma after breast-conserving therapy: Long-term outcomes with hyperfractionated radiotherapy

  • Pages: 1872-1878
  • First Published: 06 April 2010

The outcomes of 14 patients treated for angiosarcoma developing after breast-conserving therapy with hyperfractionated and accelerated radiotherapy with or without surgery at the University of Florida were retrospectively reviewed. The authors found a high rate of local control, disease-free survival, and overall survival, and believe the success with this approach is related to both the hyperfractionation and acceleration of the radiotherapy.

Gastrointestinal Disease

Free Access

Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer

  • Pages: 1879-1886
  • First Published: 06 April 2010

The authors observed that it was feasible to incorporate patient-reported outcome measurement into routine clinical care for patients with rectal cancer who were receiving concurrent chemoradiation therapy. This report describes the frequency and trajectory of gastrointestinal symptom development during treatment. Patient-reported symptoms and physician-assessed toxicity differed.

Genitourinary Disease

Free Access

Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death

  • Pages: 1887-1892
  • First Published: 06 April 2010

Prostate-specific antigen recurrence after prostatectomy is associated with an increased risk of all-cause mortality, not just prostate cancer-specific survival. Radiotherapy or hormonal therapy appears to lessen that risk.

Free Access

Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: A multicenter prospective randomized trial

  • Pages: 1893-1900
  • First Published: 06 April 2010

Gemcitabine used as second-line treatment after bacille Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer might represent a safe and effective option. Further clinical research is warranted to corroborate these findings and to define the best treatment protocol in this subset of patients.

Free Access

Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer

  • Pages: 1901-1908
  • First Published: 06 April 2010

An institutional policy mandating a minimum number of lymph nodes removed and examined during a radical cystectomy with pelvic lymphadenectomy can improve bladder cancer patient survival. The policy can lead to greater confidence in pathologic staging and reliability of lymph node density as a predictor of prognosis.

Free Access

Sex or survival: Short-term versus long-term androgen deprivation in patients with locally advanced prostate cancer treated with radiotherapy

  • Pages: 1909-1917
  • First Published: 06 April 2010

Prostate cancer survivors hypothetically are willing to trade survival to avoid long-term androgen deprivation. This needs to be an individualized decision between physician and patient.

Gynecologic Oncology

Free Access

Plasma cell-free DNA in ovarian cancer: An independent prognostic biomarker

  • Pages: 1918-1925
  • First Published: 06 April 2010

Preoperative plasma total cell-free DNA levels were found to be significantly elevated in patients with ovarian cancer compared with women with benign ovarian masses and unaffected controls. Cell-free DNA levels correlated with aggressive features, such as high stage and level of surgical cytoreduction, and most importantly, were found to be an independent predictor of shorter disease-specific survival in ovarian cancer patients.

Hematologic Malignancies

Free Access

Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical-prognostic and biologic significance

  • Pages: 1926-1937
  • First Published: 06 April 2010

In patients with chronic lymphocytic leukemia (CLL), high levels of circulating endothelial cells (CECs), as assessed by flow cytometry, identified a subset of patients with a shorter time to first treatment in both univariate and multivariate analyses. By using florescence in situ hybridization and gene expression profile analyses, cells with the CEC phenotype revealed a molecular pattern that suggested a possible derivation from CLL leukemic cells.

Hepatobiliary Disease

Free Access

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

  • Pages: 1938-1946
  • First Published: 06 April 2010

Diabetes is a significant risk factor for hepatocellular carcinoma development. However, diabetic patients who were treated with metformin or thiazolidinediones experience a 70% risk reduction of hepatocellular carcinoma compared with the use of insulin or sulfonylureas. Choosing an appropriate and safe treatment for diabetes mellitus is critical in patients with underlying liver diseases.

Neuro–Oncology

Free Access

Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis

  • Pages: 1947-1952
  • First Published: 06 April 2010

The site of intracerebrospinal fluid chemotherapy administration affects outcome of patients with neoplastic meningitis.

Sarcoma

Free Access

Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades

  • Pages: 1953-1963
  • First Published: 06 April 2010

Immunoglobulin G was identified in a variety of soft tissue tumors. The expression of immunoglobulin correlated well with tumor grade and with the proliferation markers Ki-67, proliferating cell nuclear antigen, and cyclin D1.

Free Access

Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry

  • Pages: 1964-1973
  • First Published: 06 April 2010

The California Cancer Registry was used to examine the epidemiology of Ewing sarcoma from 1989-2007 and to identify relevant prognostic factors for survival.

Discipline

Diagnostic Imaging

Free Access

Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes

  • Pages: 1974-1980
  • First Published: 06 April 2010

A study was undertaken to retrospectively evaluate the sensitivity and accuracy of and complications associated with computed tomography (CT)-guided percutaneous needle biopsy (PNB) of pulmonary hilar lesions to establish whether it is a viable alternative to endobronchial ultrasonography. CT-guided PNB of pulmonary hilar lesions was found to have high sensitivity and accuracy and to represent a viable alternative for endobronchial ultrasonography-guided fine-needle aspiration when larger biopsy samples are required for diagnosis or biomarker analysis.

Disparities Research

Free Access

Racial differences in the perception of lung cancer: The 2005 Health Information National Trends Survey

  • Pages: 1981-1986
  • First Published: 06 April 2010

The results from this review of data from the 2005 Health Information National Trends Survey indicated that African Americans are more likely to hold beliefs about lung cancer that could interfere with prevention and treatment.

Free Access

Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: A new source of bias in morbidity assessment?

  • Pages: 1987-1991
  • First Published: 06 April 2010

For lymph node-negative patients, the number of additional nonsentinel lymph nodes and thus the total number of lymph nodes removed was increased for patients with larger tumors and who were younger in age. This observed variation by tumor size and age in the total number of lymph nodes removed among patients with negative sentinel lymph nodes is a potential unrecognized source of morbidity of sentinel lymph node biopsy, and may be important in evaluating reported risk of axillary recurrence for sentinel lymph node biopsy studies.

Free Access

Women's experiences with genomic testing for breast cancer recurrence risk

  • Pages: 1992-2000
  • First Published: 06 April 2010

An examination of early stage breast cancer patients' experiences with genomic testing revealed that ⅓ of women reported suboptimal levels of perceived understanding of discussions about their recurrence risk based on the test. Approximately 25% reported experiencing distress when receiving test results, suggesting a need to further improve risk communication and treatment decision making.

Epidemiology

Free Access

Occupational sunlight exposure and risk of renal cell carcinoma

  • Pages: 2001-2010
  • First Published: 06 April 2010

Vitamin D obtained from occupational sunlight exposure may reduce the risk of renal cell carcinoma, particularly among men residing in Central Europe. In the current study, the authors observed a significant reduction in renal cancer risk among men who were exposed to increasing occupational sunlight; no association between cancer risk and sunlight exposure was observed among women.

Pathology

Free Access

Nuclear grading of primary pulmonary adenocarcinomas: Correlation between nuclear size and prognosis

  • Pages: 2011-2019
  • First Published: 06 April 2010

Nuclear morphometry is a method for quantitative measurement of histopathologic changes in the appearance of stained cell nuclei, and can be applied for estimating the malignancy of lung adenocarcinoma. Nuclear area and nuclear major dimension are 2 useful markers for evaluating the prognosis of lung adenocarcinoma.

Pediatric Oncology

Free Access

Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation

  • Pages: 2020-2030
  • First Published: 06 April 2010

The authors examined baseline and follow-up pulmonary function tests in long-term survivors of pediatric hematologic malignancies and allogeneic hematopoietic stem cell transplantation (allo-HSCT). We identified risk factors that are useful for risk-adapted monitoring and counseling, including the abnormal pre–allo-HSCT pulmonary function tests, interval from allo-HSCT, patient age, respiratory event after allo-HSCT, sex, leukemia-risk group, and hematopoietic stem cell product.

Radiation Oncology

Free Access

Circadian variation in radiation-induced intestinal mucositis in patients with cervical carcinoma

  • Pages: 2031-2035
  • First Published: 06 April 2010

A significant difference between the incidence of higher grade diarrhea in the morning and in the evening provided indirect evidence of the influence of circadian rhythm in the intestinal mucosa of the human intestine. This knowledge may facilitate treating patients with decreased toxicity to the intestinal mucosa.

Symptom Control and Palliative Care

Free Access

Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: A simultaneous care model

  • Pages: 2036-2043
  • First Published: 06 April 2010

The acute palliative care unit facilitates simultaneous care for patients receiving cancer treatment. In the current study, the authors examined the frequency and predictors associated with antineoplastic therapy use in cancer patients admitted to the acute palliative care unit at the study institution.

Free Access

Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: A randomized double-blind study

  • Pages: 2044-2052
  • First Published: 06 April 2010

This study was the first to the authors' knowledge on providing long-term ghrelin to weight-losing cancer patients in which the effects of ghrelin were evaluated on anorexia and cachexia. The results suggested that daily, long-term provision of ghrelin to weight-losing cancer patients with solid tumors supports host metabolism, improves appetite, and attenuates catabolism.

Free Access

Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI)

  • Pages: 2053-2063
  • First Published: 06 April 2010

Measuring and managing disease-related and treatment-related symptoms are critical components of care and clinical research for cancer patients. The authors report the development and psychometric validation of the M. D. Anderson Symptom Inventory gastrointestinal module (MDASI-GI), a valid, reliable, concise tool for measuring symptom severity and interference in patients with gastrointestinal cancer.